SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Performance-Based Option Pricing Model

The following assumptions were used to determine the fair values as of the grant date:

	Nine months ended September 30, 2022
	Black-Scholes
Risk-free interest rate (%)	1.62
Expected stock price volatility (%)	67.75
Expected dividend yield	—
Expected option life (in years)	6
Fair value	$	7.27

Summary of the Weighted Average Fair Value of Stock Options Granted, the Total Intrinsic Value of Stock Options Exercised and the Fair Value of Options Vested

The following table summarizes the grant date fair value of stock options that vested during the periods presented:

	Nine months ended September 30,
(in thousands, except per share data)	2023		2022
Weighted average grant date fair value of stock options granted per share	$	—	$	8.19
Intrinsic value of options exercised	—		—
Grant date fair value of stock options that vested	83		1,031

Summary of the Activity of the Entity's Stock Options

The following table summarizes the activity related to our stock options:

	Number of options	Weighted average exercise price		Weighted average contractual term (in years)	Aggregate intrinsic value (in thousands)
Outstanding as of December 31, 2022	745,277	$	27.03	4.83	$	—
Granted	—	—
Forfeited	(6,088)	25.26
Outstanding as of September 30, 2023	739,189	27.04		4.09	—
Exercisable as of September 30, 2023	543,701	25.27		3.50	—

Restricted Stock and Restricted Stock Units Activity

The following table summarizes the activity related to our restricted shares and restricted share units:

	Number of restricted shares and restricted share units
Outstanding as of December 31, 2022	755,006
Granted	890,810
Issued	(213,576)
Forfeited/canceled	(147,241)
Outstanding as of September 30, 2023	1,284,999